Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00243360
Other study ID # U18HS011113-01
Secondary ID
Status Completed
Phase N/A
First received October 21, 2005
Last updated October 21, 2005
Start date January 2001
Est. completion date July 2003

Study information

Verified date October 2005
Source Agency for Healthcare Research and Quality (AHRQ)
Contact n/a
Is FDA regulated No
Health authority United States: Federal GovernmentCanada: Health Canada
Study type Interventional

Clinical Trial Summary

The purpose of this study was to determine if a multi-faceted intervention to implement diagnostic and therapeutic algorithms for management of suspected urinary infection in nursing home residents could reduce antibiotic prescribing for urinary indications in this population.


Description:

Antibiotic use is intense in nursing homes and frequently inappropriate when prescribed for urinary indications. Evidence from randomized controlled trials suggests that treatment of asymptomatic bacteriuria, the presence of bacteria in the urine in the absence of urinary symptoms, is not beneficial. Despite this, one in three prescriptions for urinary indications are for asymptomatic bacteriuria. To improve antibiotic prescribing in this setting we conducted a cluster randomized trial of a strategy to implement diagnostic and treatment algorithms for urinary infection. 24 nursing homes were randomized to either the intervention (implemented at the nursing home level using a multi-faceted approach: small group interactive sessions for nurses, one-on-one interviews for physicians, videotapes, written material, and outreach visits) or to usual care.


Recruitment information / eligibility

Status Completed
Enrollment 0
Est. completion date July 2003
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

1. Individuals- all residents eligible

2. Nursing homes

- Free standing long term care facilities with >100 beds

- No stated policy for diagnosis or treatment of urinary tract infections

- The facility agrees to refrain from introducing new strategies for antibiotic utilization or clinical pathways during study

Exclusion Criteria:

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Educational/Counseling/Training


Related Conditions & MeSH terms


Intervention

Behavioral:
diagnostic and treatment clinical algorithms


Locations

Country Name City State
Canada McMaster University Hamilton Ontario

Sponsors (1)

Lead Sponsor Collaborator
Agency for Healthcare Research and Quality (AHRQ)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Antimicrobial prescriptions
Secondary Urinary cultures,
Secondary hospitalizations, deaths